The Hydration Pharmaceuticals Co Ltd
HPC
Company Profile
Business description
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Contact
6 Palmer Parade
Level 2, Cremorne
MelbourneVIC3121
AUST: +61 396142444
Sector
Consumer Defensive
Stock type
Defensive
Industry
Food Distribution
Fiscal Year End
Employees
Stocks News & Analysis
stocks
Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up
The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.
stocks
Takeover proposal agreed for ASX share, other offers permitted
Morningstar analysts’ take on the takeover for this undervalued industrial player.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,919.10 | 3.60 | -0.04% |
| CAC 40 | 8,142.08 | 77.06 | 0.96% |
| DAX 40 | 25,573.66 | 269.60 | 1.07% |
| Dow JONES (US) | 51,886.95 | 204.31 | 0.40% |
| FTSE 100 | 10,737.18 | 78.05 | 0.73% |
| HKSE | 25,042.71 | 291.93 | 1.18% |
| NASDAQ | 26,951.40 | 428.86 | 1.62% |
| Nikkei 225 | 65,018.95 | 882.70 | 1.38% |
| NZX 50 Index | 13,821.20 | 82.06 | 0.60% |
| S&P 500 | 7,729.11 | 78.61 | 1.03% |
| S&P/ASX 200 | 8,731.90 | 0.70 | 0.01% |
| SSE Composite Index | 3,949.91 | 38.04 | 0.97% |